Edition:
United States

Pharmacom Biovet Inc (PHMB.PK)

PHMB.PK on OTC Markets Group

0.00USD
16 Nov 2017
Change (% chg)

-- (--)
Prev Close
$0.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
422,053
52-wk High
$0.00
52-wk Low
$0.00

Chart for

About

PharmaCom BioVet Inc., formerly ABV Gold Inc., intends to introduce and further develop bone marrow transplantation and other cancer treatment procedures to benefit companion animals (canine and feline) that are diagnosed with lymphoma, other types of cancers and other diseases. The Company is introducing canine bone marrow... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $0.00
Shares Outstanding(Mil.): 856.09
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 30.21 15.79
EPS (TTM): -- -- --
ROI: -- 7.97 12.01
ROE: -- 11.82 15.91

Earnings vs. Estimates

No consensus analysis data available.